PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
30-Nov-2020 Dupixent® (dupilumab) approved by European Commission as first and only biologic medicine for children aged 6 to 11 years with severe atopic dermatitis Sanofi
30-Nov-2020 Khondrion shares progress of sonlicromanol development programme at Mitochondrial Medicine 2020 virtual conference Khondrion
30-Nov-2020 VAL201 Clinical Trial Full Data Results ValiRx plc
30-Nov-2020 Forxiga approved in Japan for chronic heart failure AstraZeneca
30-Nov-2020 Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization Moderna
30-Nov-2020 Autolus Therapeutics announces publication of new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medicine Autolus Therapeutics plc
27-Nov-2020 Sharing the evidence to help tackle COVID-19 The University of Huddersfield
27-Nov-2020 UK TECH SPINOUT SALIENT BIO LAUNCHES FASTEST EVER ROBOTIC COVID-19 PCR-BASED TESTS WITH A GOLD STANDARD ACCURACY OF OVER 99% Salient Bio
27-Nov-2020 Coulter Partners and BioInnovation Institute announce partnership agreement Coulter Partners
27-Nov-2020 Qiagen doubles its R&D facilities in the Barcelona Science Park to increase action capacity against COVID-19 Qiagen N.V
27-Nov-2020 Vertex Announces European Commission Approval for SYMKEVI® (tezacaftor/ivacaftor) With KALYDECO® (ivacaftor) for Eligible Children With Cystic Fibrosis Ages 6-11 Years Vertex
27-Nov-2020 Interview Released with Robert Vries, CEO at Hubrecht Organoid Technology speaker at 3D Cell Culture SMi Group
25-Nov-2020 Celltrion completes enrolment for global Phase II clinical trial with COVID-19 treatment candidate CT-P59 Celltrion
20-Nov-2020 SMi’s 2nd Annual AI in Drug Discovery Announces key industry speakers and agenda released SMi Group
19-Nov-2020 COVID-19: Treatment for the Most Severely Affected Patients - After Promising Results in Named Patient Use - Clinical Trial with FX06 Starts in France F4 Pharma
19-Nov-2020 Medidata and Oxford University Innovation’s Clinical Outcomes Team Announce Addition of Gold Standard Questionnaires to eCOA Library Medidata
19-Nov-2020 One week to go Webinar on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular Hiving™ Technology  SMi Group
18-Nov-2020 PureTech’s LYT-100 (Deupirfenidone) Demonstrates Tolerability and Pharmacokinetic Proof-of-Concept in Phase 1 Multiple Ascending Dose and Food Effect Study PureTech
18-Nov-2020 BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100 BioVersys
18-Nov-2020 PTC Therapeutics Announces that PTC518 Has Entered into a Phase 1 Clinical Trial for the Huntington’s Disease Program PTC Therapeutics